stalevo 20050200 mg
inovamed pharma ltd, israel - carbidopa as monohydrate; entacapone; levodopa - film coated tablets - levodopa 200 mg; entacapone 200 mg; carbidopa as monohydrate 50 mg - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.
stalevo 7518.75200
inovamed pharma ltd, israel - carbidopa as monohydrate; entacapone; levodopa - film coated tablets - carbidopa as monohydrate 18.75 mg; entacapone 200 mg; levodopa 75 mg - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa/decarboxylase (ddc) inhibitor treatment.
rytmonorm 150 mg
abbott medical laboratories ltd, israel - propafenone hydrochloride - film coated tablets - propafenone hydrochloride 150 mg - antiarrhythmics, class ic - prophylaxis and treatment of ventricular arrhythmias. prophylaxis and treatment of atrial fibrillation and flutter. prophylaxis and treatment of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms.
rythmex 150 mg
abbott medical laboratories ltd, israel - propafenone hydrochloride - film coated tablets - propafenone hydrochloride 150 mg - antiarrhythmics, class ic - prophylaxis and treatment of ventricular arrhythmias. prophylaxis and treatment of atrial fibrillation and flutter. prophylaxis and treatment of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms.
rytmonorm 300 mg
abbott medical laboratories ltd, israel - propafenone hydrochloride - film coated tablets - propafenone hydrochloride 300 mg - antiarrhythmics, class ic - prophylaxis and treatment of ventricular arrhythmias. prophylaxis and treatment of atrial fibrillation and flutter. prophylaxis and treatment of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms.
rythmex 300 mg
abbott medical laboratories ltd, israel - propafenone hydrochloride - film coated tablets - propafenone hydrochloride 300 mg - antiarrhythmics, class ic - prophylaxis and treatment of ventricular arrhythmias. prophylaxis and treatment of atrial fibrillation and flutter. prophylaxis and treatment of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms.
finolim 0.5 mg
rafa laboratories ltd - fingolimod as hydrochloride - capsules - fingolimod as hydrochloride 0.5 mg - fingolimod - treatment of patients with relapsing forms of multiple sclerosis (ms) to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability.
tardyferon
padagis israel agencies ltd, israel - ferrous sulfate - tablets - ferrous sulfate 247.25 mg - iron bivalent, oral preparations - prevention and treatment of iron deficiency anemia.
mycoster 8 % nail lacquer
perrigo israel agencies ltd - ciclopirox - lacque - ciclopirox 8 %w/w - ciclopirox - treatment of fungal infections of the nails.
capd 2 peritoneal dialysis solution
fresenius medical care israel p.b. ltd - calcium chloride; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - magnesium chloride 0.1017 g/l; sodium chloride 5.786 g/l; calcium chloride 0.2573 g/l; glucose as monohydrate 16.5 g/l; lactic acid as sodium 3.925 g/l - combinations of electrolytes - combinations of electrolytes - for use in patients with end-stage (decompensated) chronic renal failure of any origin being maintained on peritoneal dialysis.